Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome Structure

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Control of SIINFEKL Antigen Presentation by the Immunoproteasome.

Chembiochem : a European journal of chemical biology·2026

Same author

<i>In Vivo</i> Time-Lapse Imaging Reveals Differential Activity-Induced Regulation of Proteasome Activity in Subcellular Regions of the Optic Tectum in <i>Xenopus laevis</i> Tadpoles.

ACS chemical neuroscience·2026

Same author

You are what you degrade: tracking the cellular fates of the proteasomal degradome.

Molecular omics·2026

Same author

Increasing Proteasome Activity to Alter XBP1 Signaling of the UPR Pathway.

Chembiochem : a European journal of chemical biology·2026

Same author

Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity.

Angewandte Chemie (International ed. in English)·2025

Same author

Synthesis of Immunoproteasome N-Degron Prodrugs for Selective Protein Degradation.

Current protocols·2025

Search research articles

Related Experiment Video

Updated: Sep 16, 2025

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

Exploring the immunoproteasome's substrate preferences for improved hydrolysis and selectivity.

Christine S Muli¹, Cody A Loy², Darci J Trader^1,2,3

¹Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University 575 West Stadium Avenue West Lafayette Indiana 47907 USA.

RSC Chemical Biology

|July 10, 2025

Summary

Researchers identified modifications to peptide-conjugated substrates that enhance selectivity for the immunoproteasome (iCP) by over threefold. This discovery aids in designing targeted iCP probes, prodrugs, and inhibitors for therapeutic applications.

More Related Videos

Defining Substrate Specificities for Lipase and Phospholipase Candidates

Defining Substrate Specificities for Lipase and Phospholipase Candidates

Published on: November 23, 2016

Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique

Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique

Published on: July 19, 2019

Related Experiment Videos

Last Updated: Sep 16, 2025

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

Defining Substrate Specificities for Lipase and Phospholipase Candidates

Defining Substrate Specificities for Lipase and Phospholipase Candidates

Published on: November 23, 2016

Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique

Evaluation of Protein–Protein Interactions using an On-Membrane Digestion Technique

Published on: July 19, 2019

Area of Science:

Biochemistry
Molecular Biology
Proteasome Biology

Background:

The proteasome is crucial for regulated protein degradation.
The immunoproteasome (iCP) is an inflammatory proteasome isoform with altered catalytic subunits.
iCP-targeting agents are developed for therapeutics and diagnostics.

Purpose of the Study:

To investigate unnatural substrate recognition by the immunoproteasome (iCP).
To optimize peptide-conjugated substrates for improved iCP selectivity.
To guide the design of novel iCP-targeting agents.

Main Methods:

Synthesis of novel peptide-conjugated substrates.
Incubation with purified human immunoproteasome (iCP).
Analysis using liquid chromatography-mass spectrometry (LC-MS).

Main Results:

Structure-activity relationships of synthesized substrates were determined.
Modifications improved iCP substrate selectivity by over 3-fold.
Identified key features for enhanced iCP recognition.

Conclusions:

Optimized peptide scaffolds significantly enhance immunoproteasome (iCP) substrate selectivity.
Findings provide a basis for designing improved iCP-specific probes and therapeutics.
This research advances the development of targeted iCP-based drug delivery systems.